News of Note—U.K. research hub, Bavarian Nordic and more

newspaper
In this week's news of note, Bavarian Nordic named a new CFO. (Pixabay)

Here is some other vaccine news of note for the week.

> Officials in the U.K. outlined a plan for a vaccine research hub to help prevent and respond to outbreaks more effectively. Release

> Bavarian Nordic appointed Henrik Juuel, who has served at Novo Nordisk and Virgin Mobile, as its new CFO. Release

> In an animal study, National Institute of Allergy and Infectious Diseases researchers reported that an HIV vaccine targeting a vulnerable site on the virus elicited antibodies against dozens of strains from around the world. Release

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.